Cephalon Makes A Deal

Cephalon Makes A Deal

There are 1 comment on the Fool.com story from Aug 27, 2007, titled Cephalon Makes A Deal. In it, Fool.com reports that:

Amrix was developed by the recently IPOed Italian drugmaker Eurand and then out-licensed to privately held ECR Pharmaceuticals, which licensed it to Cephalon. via Fool.com

Join the discussion below, or Read more at Fool.com.



#1 Aug 27, 2007
Very interesting indeed.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Wyeth Discussions

Title Updated Last By Comments
News Earnings Preview: Pfizer to report 2Q earnings (Aug '10) Jan '16 Sharolyn 18
News Wyeth's Pristiq, A New Treatment For Major Depr... (May '08) Jan '14 Vikkie 3
News Wyeth's Pristiq, a New Treatment for Major Depr... (Jul '08) Jan '14 Trixy 6
News Lilly's Results Run the Gamut (Oct '08) Sep '13 Hugh 2
News Wyeth to Pay $134.5M in Hormone Drug Case (Nov '07) Sep '13 Elliot 8
News Wyeth hit with $134.5M judgment over hormone re... (Oct '07) Sep '13 William 3
ativan untill 2003 Wyeth product (Feb '08) Mar '13 patient 9
More from around the web